Medical Health Cluster

Ingles

Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1

Researchers have identified an antibody that broadly neutralized all tested SARS-CoV-2 subvariants as well as SARS-CoV-1 in laboratory experiments and several SARS-CoV-2 variants of concern in mice. Because it targets a spike protein area that may be less affected by genetic variations, the newly discovered antibody could better retain potency against emerging […]

Read More

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

ACKGROUND The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation. METHODS In an international, randomized, double-blind, placebo-controlled, phase 3 trial, we randomly assigned adult participants in a 1:1 ratio to receive a […]

Read More

New Data on Heterologous COVID-19 Vaccine Combinations

Switching to a different COVID-19 vaccine after a first dose of the Sputnik V C1, ChAdOx1-S, or BBIBP-CorV vaccines can greatly increase immune response while maintaining safety, according to a study published in Cell Reports Medicine. The results provide information for mixing vaccine types in both primary vaccination and vaccine booster schedules, which […]

Read More

Treatment of Genetic Diseases With CRISPR Genome Editing

In nature, microorganisms use CRISPR (clustered regularly interspaced palindromic repeats) and CRISPR-associated (Cas) proteins for antiviral immunity through recognition and destruction of specific DNA sequences. Over the past decade, CRISPR genome editing has been developed to create transformative technologies to treat, cure, and prevent human disease. How CRISPR Works CRISPR […]

Read More

Public Health Leaders End Weekly Testing Requirements for Workers

SACRAMENTO – To better align state COVID-19 guidance with the most current federal recommendations, the California Department of Public Health (CDPH) is ending COVID-19 policies that required weekly COVID-19 testing for unvaccinated individuals in high-risk workplaces and schools. Health care facilities, other congregate settings and schools will no longer be […]

Read More

WHO: At least 17 million people in the WHO European Region experienced long COVID in the first two years of the pandemic; millions may have to live with it for years to come

WHO/Europe urges countries to take post COVID-19 condition seriously by urgently investing in research, recovery, and rehabilitation. New modeling conducted for WHO/Europe by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine in the United States shows that in the first two years of the […]

Read More

COVID-19 projections: best measured by hospital admissions

IHME produced its latest COVID-19 model run on September 9. Key takeaways: Global infections peaked in August and are currently declining. We expect infections to increase in the Northern Hemisphere in October through the end of 2022, but we do not expect this to lead to major increases in severe disease and […]

Read More